143

Neurology
Focuses on brain health.
Sub Categories on Neurology
Latest Articles
Alzheimer's disease – don't give up on plaque-busting drugs just yet

Alzheimer's disease – don't give up on plaque-busting drugs just yet

by Davide Bruno,The ConversationCredit: AI-generated imageAlzheimer's disease is associated with abuild-up of plaquesin the brain called amyloid beta. These plaques are thought t

Alzheimer's disease – don't give up on plaque-busting drugs just yet

by Davide Bruno,The ConversationCredit: AI-generated imageAlzheimer's disease is associated with abuild-up of plaquesin the brain called amyloid beta. These plaques are thought t
Good timing: Study unravels how our brains track time

Good timing: Study unravels how our brains track time

by Keyonna Summers,University of Nevada, Las VegasA UNLV research team explored how the brain tells time. Credit: Talha K. Soluoku/UNLVEver hear the old adage that time flies when you're hav

Good timing: Study unravels how our brains track time

by Keyonna Summers,University of Nevada, Las VegasA UNLV research team explored how the brain tells time. Credit: Talha K. Soluoku/UNLVEver hear the old adage that time flies when you're hav
Researchers make key improvements to Parkinson's disease cell therapies

Researchers make key improvements to Parkinson's disease cell therapies

JULY 13, 2023byMass General BrighamCredit: Pixabay/CC0 Public DomainCell therapy holds promise as a new treatment for Parkinson's disease but, in many trials to date, most transplanted dopam

Researchers make key improvements to Parkinson's disease cell therapies

JULY 13, 2023byMass General BrighamCredit: Pixabay/CC0 Public DomainCell therapy holds promise as a new treatment for Parkinson's disease but, in many trials to date, most transplanted dopam
Clinical trial suggests ALS drug effective for treating spinal cord injuries

Clinical trial suggests ALS drug effective for treating spinal cord injuries

by Laurie Fickman,University of HoustonRiluzole trough and peak concentrations from Phase I and Phase II/III trials presented in waterfall plots. Credit:Journal of Neurotrauma(2023).

Clinical trial suggests ALS drug effective for treating spinal cord injuries

by Laurie Fickman,University of HoustonRiluzole trough and peak concentrations from Phase I and Phase II/III trials presented in waterfall plots. Credit:Journal of Neurotrauma(2023).
Is Alzheimer's caused by disruptions to the brain's energy supply?

Is Alzheimer's caused by disruptions to the brain's energy supply?

by Kira Shaw And Orla Bonnar,The ConversationCredit: AI-generated imageIt is well known that Alzheimer's disease, the most common form of dementia, involves the accumulation of sticky protei

Is Alzheimer's caused by disruptions to the brain's energy supply?

by Kira Shaw And Orla Bonnar,The ConversationCredit: AI-generated imageIt is well known that Alzheimer's disease, the most common form of dementia, involves the accumulation of sticky protei
Presence hallucinations: An early predictor of cognitive decline in Parkinson's disease

Presence hallucinations: An early predictor of cognitive decline in Parkinson's disease

by Ecole Polytechnique Federale de LausanneEarly hallucinations in Parkinson's disease are associated with frontal cognitive decline (triangles), and preceded by specific frontal neural oscil

Presence hallucinations: An early predictor of cognitive decline in Parkinson's disease

by Ecole Polytechnique Federale de LausanneEarly hallucinations in Parkinson's disease are associated with frontal cognitive decline (triangles), and preceded by specific frontal neural oscil
Is a commonly-used screening tool for cognitive impairment accurate in diverse populations?

Is a commonly-used screening tool for cognitive impairment accurate in diverse populations?

by WileyCredit: Pixabay/CC0 Public DomainA screening tool often used in primary care clinics to detect cognitive impairment has shortcomings when applied to ethnically and linguistically diverse

Is a commonly-used screening tool for cognitive impairment accurate in diverse populations?

by WileyCredit: Pixabay/CC0 Public DomainA screening tool often used in primary care clinics to detect cognitive impairment has shortcomings when applied to ethnically and linguistically diverse
Alzheimer's diagnosis, management improved by brain scans

Alzheimer's diagnosis, management improved by brain scans

by Alzheimer's AssociationAmyloid-positive (left) and amyloid-negative (right) PET scans can respectively be used to diagnose or rule out Alzheimer's disease in individuals with memory loss or

Alzheimer's diagnosis, management improved by brain scans

by Alzheimer's AssociationAmyloid-positive (left) and amyloid-negative (right) PET scans can respectively be used to diagnose or rule out Alzheimer's disease in individuals with memory loss or
Geometry of brain, dimensions of mind: Researchers identify new ways to characterize states of consciousness

Geometry of brain, dimensions of mind: Researchers identify new ways to characterize states of consciousness

by Kelly Malcom,University of MichiganSchematic illustration of three working hypotheses. Hypothesis 1: Dimensions of consciousness are encoded in multiple neurofunctional dimensions of the brai

Geometry of brain, dimensions of mind: Researchers identify new ways to characterize states of consciousness

by Kelly Malcom,University of MichiganSchematic illustration of three working hypotheses. Hypothesis 1: Dimensions of consciousness are encoded in multiple neurofunctional dimensions of the brai
Good news, bad news from Alzheimer's vaccine trial

Good news, bad news from Alzheimer's vaccine trial

by Marianne Madeiros and Robin FosterAn experimental Alzheimer's vaccine appears to safely clear abnormal tau protein from the brain, but it's not yet clear whether the shot will be able to sa

Good news, bad news from Alzheimer's vaccine trial

by Marianne Madeiros and Robin FosterAn experimental Alzheimer's vaccine appears to safely clear abnormal tau protein from the brain, but it's not yet clear whether the shot will be able to sa
Synthetic peptide can inhibit toxicity, aggregation of protein in Alzheimer's disease

Synthetic peptide can inhibit toxicity, aggregation of protein in Alzheimer's disease

by University of WashingtonPET scan of a human brain with Alzheimer's disease. Credit: public domainAlzheimer's is a disease of aggregation. Neurons in the human brain make a protein call

Synthetic peptide can inhibit toxicity, aggregation of protein in Alzheimer's disease

by University of WashingtonPET scan of a human brain with Alzheimer's disease. Credit: public domainAlzheimer's is a disease of aggregation. Neurons in the human brain make a protein call
Silencing a faulty gene may uncover clues to rare forms of ALS

Silencing a faulty gene may uncover clues to rare forms of ALS

by National Institutes of HealthCredit: Pixabay/CC0 Public DomainUsing an experimental drug, researchers have been able to suppress a mutated amyotrophic lateral sclerosis (ALS) gene. Studies in

Silencing a faulty gene may uncover clues to rare forms of ALS

by National Institutes of HealthCredit: Pixabay/CC0 Public DomainUsing an experimental drug, researchers have been able to suppress a mutated amyotrophic lateral sclerosis (ALS) gene. Studies in